Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer.
Unal B, Kuzu OF, Jin Y, Osorio D, Kildal W, Pradhan M, Kung SHY, Oo HZ, Daugaard M, Vendelbo M, Patterson JB, Thomsen MK, Kuijjer ML, Saatcioglu F.
Unal B, et al.
Nat Commun. 2024 Oct 15;15(1):8895. doi: 10.1038/s41467-024-53039-1.
Nat Commun. 2024.
PMID: 39406723
Free PMC article.